PUBLISHER: The Business Research Company | PRODUCT CODE: 1951693
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951693
Deoxyribonucleic acid (DNA) nanotechnology is a discipline that leverages the molecular structure and base-pairing characteristics of DNA to design and build nanoscale structures and devices. It focuses on creating precise, programmable assemblies using DNA strands. Its primary goal is to develop innovative materials, biosensors, and molecular machines for applications in medicine, diagnostics, and nanofabrication.
The main categories of DNA nanotechnology include dynamic DNA nanotechnology and structural DNA nanotechnology. Dynamic DNA nanotechnology allows for programmable systems that respond to molecular signals for targeted drug delivery, biosensing, and autonomous operations. It is available in different formulations, such as water-soluble, oil-soluble, and hybrid types, and is distributed through multiple channels, including online platforms, direct sales, retail outlets, and distributors or wholesalers. It is utilized in applications like smart pills, nanolithography, targeted drug delivery, and more, serving end-users such as academic and research institutions, biotechnology and pharmaceutical companies, and others.
Tariffs have impacted the DNA nanotechnology market by increasing costs of imported reagents, oligonucleotides, and laboratory instruments essential for DNA nanostructure synthesis and applications. Segments like dynamic and structural DNA nanotechnology, especially for academic and biotechnology applications, are most affected, with North America, Europe, and Asia-Pacific regions facing the greatest impact. While tariffs have raised operational costs and slowed procurement of materials, they have also encouraged local synthesis, innovation in cost-effective DNA nanomaterials, and development of domestic research capabilities.
The deoxyribonucleic acid (dna) nanotechnology market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (dna) nanotechnology market statistics, including deoxyribonucleic acid (dna) nanotechnology industry global market size, regional shares, competitors with a deoxyribonucleic acid (dna) nanotechnology market share, detailed deoxyribonucleic acid (dna) nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (dna) nanotechnology industry. This deoxyribonucleic acid (dna) nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The deoxyribonucleic acid (dna) nanotechnology market size has grown exponentially in recent years. It will grow from $6.97 billion in 2025 to $8.75 billion in 2026 at a compound annual growth rate (CAGR) of 25.5%. The growth in the historic period can be attributed to emergence of dna nanotechnology research, increasing academic and pharmaceutical investments, development of basic dna nanostructures, growing demand for precision medicine, early adoption in drug delivery and diagnostics.
The deoxyribonucleic acid (dna) nanotechnology market size is expected to see exponential growth in the next few years. It will grow to $21.48 billion in 2030 at a compound annual growth rate (CAGR) of 25.2%. The growth in the forecast period can be attributed to integration with biosensing and theranostic applications, expansion of water-soluble and hybrid formulations, rising funding for nanomedicine research, increasing commercialization through online and direct sales, adoption in advanced nanofabrication techniques. Major trends in the forecast period include advancements in dna-based nanomachines and logic gate systems, growth in dna origami and tile-based nanostructures, increased use of dna nanotechnology for targeted drug delivery, expansion of nanolithography and smart pill applications, development of hybrid and multifunctional dna nanostructures.
The increasing prevalence of genetic diseases is expected to drive the growth of the deoxyribonucleic acid (DNA) nanotechnology market in the coming years. Genetic diseases are disorders caused by DNA changes or mutations, which can be inherited or occur spontaneously, affecting health, development, or bodily functions. The rise in these conditions is largely due to greater awareness and advancements in diagnostic technologies, which allow for earlier and more accurate detection of previously undiagnosed disorders. DNA nanotechnology addresses genetic diseases by enabling precise targeting of defective genes, supporting accurate diagnosis and personalized treatments. It enhances therapeutic outcomes through controlled drug delivery and gene editing, improving patient care and disease management. For example, according to the National Blood Authority in Australia, 2,788 patients were living with hereditary haemophilia A (HMA) in 2023-2024, up from 2,681 patients in 2022-2023. This growing prevalence of genetic disorders is therefore fueling the expansion of the DNA nanotechnology market.
Key players in the DNA nanotechnology market are focusing on advanced solutions, such as artificial-intelligence-based DNA sequencing, to enhance accuracy and enable more precise molecular diagnostics and nanodevice design. AI-based DNA sequencing leverages artificial intelligence to rapidly analyze and interpret DNA data, improving speed, accuracy, and personalized disease detection. For instance, in May 2025, the Indian Institute of Technology launched quantum AI nanotechnology capable of rapid, highly accurate, and cost-effective early detection of genetic mutations, including those associated with cancer. This technology combines explainable AI with quantum transport mechanisms to decode raw electrical signals from DNA sequencing with unmatched precision. The quantum-AI approach uses solid-state nanopore or nanogap devices that capture unique electronic signatures of nucleotides, enabling comprehensive detection of natural, epigenetic, and artificial DNA mutations. This innovation has the potential to transform genomics, personalized medicine, and cancer diagnostics by enabling early mutation detection and tailored treatment strategies.
In January 2025, Maravai LifeSciences, a US-based life sciences company, acquired the assets and intellectual property of Molecular Assemblies for an undisclosed sum. Through this acquisition, Maravai aims to accelerate innovation in high-fidelity, scalable oligonucleotide production to support emerging applications in genetic medicine, synthetic biology, and advanced research, facilitating faster development cycles, improved manufacturing efficiency, and wider access to precision-engineered nucleic acid solutions. Molecular Assemblies, a US-based biotechnology firm, specializes in enzymatic DNA synthesis technologies that produce high-purity, application-ready genetic materials.
Major companies operating in the deoxyribonucleic acid (dna) nanotechnology market are Twist Bioscience Corporation, SomaLogic Inc., Alamar Biosciences Inc., Nanion Technologies GmbH, Eligo Bioscience SA, DNA Nanobots LLC, Nanovery Limited, Parabon NanoLabs Inc., tilibit nanosystems GmbH, Luna Nanotech Inc., Code Biotherapeutics Inc., Sona Nanotech Inc., Cello Therapeutics Inc., Esya Labs Inc., NuProbe Global Inc., Ansa Biotechnologies Inc., GATTAquant GmbH, ARIZ Precision Medicine Inc., NanoApps Medical Inc., Aura Biosciences Inc.
North America was the largest region in the deoxyribonucleic acid (DNA) nanotechnology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) nanotechnology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the deoxyribonucleic acid (dna) nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The deoxyribonucleic acid (DNA) nanotechnology market consists of revenues earned by entities by providing services such as custom deoxyribonucleic acid nanostructure design, deoxyribonucleic acid nanostructure synthesis and fabrication, targeted drug delivery solutions using deoxyribonucleic acid nanostructures, and research and development contract services. The market value includes the value of related goods sold by the service provider or included within the service offering. The deoxyribonucleic acid (DNA) nanotechnology market also includes of sales of DNA nanorobots, DNA scaffolds for nanofabrication, DNA computing systems and DNA origami structures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Deoxyribonucleic Acid (DNA) Nanotechnology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses deoxyribonucleic acid (dna) nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for deoxyribonucleic acid (dna) nanotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) nanotechnology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.